Privacy Policy
Signals Blog

Contributors

Categories

Regenerative Medicine Deal Review: May

. Welcome to your deal review for the month of May. Juno Therapeutics was active, forming a strategic research collaboration with Fate Therapeutics and acquiring Stage Cell Therapeutics. Adaptimmune decided it would take advantage of the ongoing initial public...

Right Turn: Moving RM discoveries to the market, in Ontario

.Today is a big day for the regenerative medicine (RM) community in Ontario, Canada. Minister of Research and Innovation, Reza Moridi, just announced that the Ontario Institute for Regenerative Medicine (OIRM) will receive a new $25 million commitment* (in addition to...

Right Turn: 3D prosthetics provide a helping hand

. Anthony Atala MD, of Wake Forest University, is a pioneer in the field of regenerative medicine and recognized for his trailblazing and visionary work in tissue engineering and building printable organs. Signals has somehow missed out on featuring his work, despite...

‘Smart bandage’ for timely detection of bedsores

. Some of my fond memories of childhood are from the times that my great grandma and grandpa visited us. They told us sweet stories and shared memories of much simpler times. But they had worries too. I vividly remember that one of my great grandmother’s main fears...

Right Turn: Making stem cells Crystal clear in TEDx talk

. Crystal Ruff is a Canadian regenerative neuroscience researcher who appears to have a fondness for stem cells, communicating science and London, England (not necessarily in that order). She studied at the undergraduate level at McMaster University in Hamilton,...

Stem cells as the road to repairing Multiple Sclerosis

. A clinical trial set to begin this month in Ottawa will test the safety and efficacy of mesenchymal stem cells to stimulate repair of damaged nerves in MS patients. This article was published simultaneously on the Ontario Institute for Regenerative Medicine website....

Right Turn: Crowdsourcing science – the power of many

. Camila Londono is currently an intern at CCRM, taking a break from working on her PhD at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto under the supervision of Dr. Alison McGuigan. Her research focuses on understanding what...

Regenerative Medicine Deal Review: April

. Welcome to your deal review for the month of April. There is no update yet on the fate of the Cellular Dynamics International/Fujifilm deal, but it appears that CDI made some effort to solicit offers from alternative bidders. Aduro made headlines, though, closing a...

Update from the Clinic: April

. Welcome to your Update from the Clinic for the month of April. Mesenchymal stem cells took a hit as Athersys’ MultiStem came up short, missing its primary endpoint in a Phase 2 study investigating the cells for ischemic stroke. Juno Therapeutics continues to turn...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!